Page last updated: 2024-12-05

2,3-dichlorophenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dichlorophenol : Any chlorophenol carrying chloro substituents. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11334
CHEMBL ID16656
SCHEMBL ID134755
MeSH IDM0242780

Synonyms (51)

Synonym
nsc60646
nsc-60646
phenol,3-dichloro-
576-24-9
2,3-dichlorophenol
inchi=1/c6h4cl2o/c7-4-2-1-3-5(9)6(4)8/h1-3,9
phenol, 2,3-dichloro-
NCGC00091161-01
nsc 60646
ccris 5902
2,3-dcp
hsdb 4264
einecs 209-399-8
brn 2043615
2,3-dichlorophenol, 98%
AC-10660
D0391
CHEMBL16656
AKOS000120221
2,3-bis(chloranyl)phenol
A831528
NCGC00091161-02
dtxsid7025001 ,
dtxcid905001
NCGC00258463-01
tox21_200909
cas-576-24-9
25167-81-1
dichlorophenol
izm39u444l ,
unii-izm39u444l
4-06-00-00883 (beilstein handbook reference)
FT-0609574
dichlorophenol, 2,3-
2,3-dichlorophenol [hsdb]
2-dichloro phenol
2,3-dichloro phenol
2,3 dichlorophenol
SCHEMBL134755
W-105454
mfcd00002160
5jf ,
2,3-dichlorophenol, analytical standard
phenol, 2,3-dichloro-; 2,3-dichlorophenol; nsc 60646
2,3-dichlorophenol 10 microg/ml in methanol
F0001-1499
BCP21197
AS-14412
EN300-20355
Q27280968
Z104477856
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (15)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency89.72300.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency15.53660.006038.004119,952.5996AID1159521; AID1159523
AR proteinHomo sapiens (human)Potency68.86870.000221.22318,912.5098AID1259247
thyroid stimulating hormone receptorHomo sapiens (human)Potency0.02510.001318.074339.8107AID926; AID938
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency68.86870.000657.913322,387.1992AID1259377
progesterone receptorHomo sapiens (human)Potency5.47040.000417.946075.1148AID1346795
retinoid X nuclear receptor alphaHomo sapiens (human)Potency55.16290.000817.505159.3239AID1159527
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency45.87840.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401
estrogen nuclear receptor alphaHomo sapiens (human)Potency17.44400.000229.305416,493.5996AID743069
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency61.89380.001024.504861.6448AID743212
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency12.34940.001019.414170.9645AID743191
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency47.78890.057821.109761.2679AID1159526; AID1159528
potassium voltage-gated channel subfamily H member 2 isoform dHomo sapiens (human)Potency5.01190.01789.637444.6684AID588834
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency27.41710.000323.4451159.6830AID743065
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency47.30790.000627.21521,122.0200AID651741
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's5 (55.56)29.6817
2010's2 (22.22)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.19 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]